These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8261491)

  • 1. Left ventricular mass regression and diastolic function improvement in mild and moderate hypertensive patients treated with lisinopril.
    Esper RJ; Burrieza OH; Cacharrón JL; Fábregues G; Baglivo HP
    Cardiology; 1993; 83(1-2):76-81. PubMed ID: 8261491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of ACE-inhibition on myocardial mass and diastolic function in chronic hemodialysis patients with adequate control of blood pressure.
    Roithinger FX; Punzengruber C; Wallner M; Ulbrich W; Pachinger O; Kramar R; Prischl FC
    Clin Nephrol; 1994 Nov; 42(5):309-14. PubMed ID: 7851032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
    Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
    Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study).
    Palmieri V; Bella JN; DeQuattro V; Roman MJ; Hahn RT; Dahlof B; Sharpe N; Lau CP; Chen WC; Paran E; de Simone G; Devereux RB
    Am J Cardiol; 1999 Sep; 84(5):558-62. PubMed ID: 10482155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of antihypertensive therapy on left ventricular mass and diastolic filling in light and moderate hypertension].
    Salcedo A; Lekuona I; Laraudogoitia E; Echevarría P; Madariaga JA; Palomar S; Zumalde J; Barrenetxea JI
    Med Clin (Barc); 1993 May; 100(17):646-50. PubMed ID: 8497169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of diltiazem and lisinopril on left ventricular structure and filling in mild-to-moderate hypertension.
    van Leeuwen JT; Smit AJ; May JF; ten Berge BS; Hamer HP; Havinga TK; Schuurman FH; van der Veru E; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):983-9. PubMed ID: 8606538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension.
    Fogari R; Zoppi A; Mugellini A; Tettamanti F; Lusardi P; Corradi L
    Eur Heart J; 1995 Aug; 16(8):1120-5. PubMed ID: 8665975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients.
    Beltman F; Heesen W; Smit A; May J; de Graeff P; Havinga T; Schuurman F; van der Veur E; Lie K; Meyboom-de Jong B
    J Hypertens Suppl; 1998 Oct; 16(6):S15-9. PubMed ID: 9856379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
    Ito O; Okamoto M; Murakami Y; Nakayama R
    J Cardiol; 1991; 21(4):931-41. PubMed ID: 1844449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of short-term lisinopril administration on left ventricular filling dynamics in hypertensive patients with diastolic dysfunction.
    Cuspidi C; Lonati L; Sampieri L; Leonetti G; Muiesan ML; Agabiti-Rosei E; Zanchetti A
    Blood Press; 1997 Sep; 6(5):307-12. PubMed ID: 9360002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial.
    Terpstra WF; May JF; Smit AJ; de Graeff PA; Havinga TK; van den Veur E; Schuurman FH; Meyboom-de Jong B; Crijns HJ
    J Hypertens; 2001 Feb; 19(2):303-9. PubMed ID: 11212974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A double ambulatory product (blood pressure and heart rate), mild arterial hypertension and left ventricular hypertrophy].
    Azevedo J; Arroja I; Jacques A; Santos I; Amado P; Marques JC; Araújo V
    Rev Port Cardiol; 1993; 12(7-8):663-73, 602. PubMed ID: 8352987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of heart rate variability and smoothness index on the reversal of hypertensive left ventricular hypertrophy].
    Wang HB; Shi Q; Zhang C
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):832-5. PubMed ID: 21600164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of regression of left ventricular hypertrophy on cardiac function in hypertension.
    Omotoso AB; Dunn FG
    Eur Heart J; 1992 Sep; 13 Suppl D():107-10. PubMed ID: 1396853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.